Breast Cancer Clinical Trial
Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
Summary
The purpose of this study is to observe the routine clinical care of patients who have been diagnosed with breast cancer and have undergone Guardant360 testing.
Full Description
Patients who have been diagnosed with breast cancer and have undergone Guardant360 testing will be approached regarding participation in the study. After being informed about the study and potential risks, all patients providing informed consent and access to their medical records, will provide a list of their health care providers related to their cancer treatment. Data related to their routine clinical care will be abstracted from medical records.
Eligibility Criteria
Inclusion Criteria:
Adults (18 years of age and older) with a diagnosis of breast cancer
Guardant360 test results released to the patient's physician no less than 14 days prior to initial patient contact
Patient has previously provided contact information (either email or phone) to Guardant Health
Able and willing to complete the electronic informed consent process
Must have access to a computer terminal or personal computing device
Willingness to consent to the release of medical records
Exclusion Criteria:
1. Unable to understand English
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Redwood City California, 94063, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.